title: Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks.
abstract: The primary aim of these guidelines is to assist individual clinicians, hospital departments, and hospital administrators to produce local protocols for the: • assessment, investigation and immediate management of individuals with a transient ischemic attack or acute stroke (other than sub-arachnoid hemorrhage), and • secondary prevention and risk factor management following a transient ischemic attack or acute stroke. The secondary aim of these guidelines is to suggest methods for implementation and clinical audit. The workgroup preparing these guidelines was formed by the Ministry of Health, Singapore. It comprised healthcare workers from relevant specialties, family medicine, nursing, occupational therapy, and a lay patient advocate. The Scottish Intercollegiate Guidelines Network's Clinical Practice Guidelines on the Management of Patients with Stroke were reviewed, updated, and modified to meet local needs. The final guidelines are made up of evidence-based recommendations covering the following areas - assessment, investigation, immediate management, secondary prevention, rehabilitation, and implications for service delivery. The guidelines were sent to professional organizations for comments and endorsements. The final version was circulated to all medical practitioners in Singapore. It is hoped that the guidelines will improve the care of patients with stroke and transient ischemic attack. Clinical quality improvement measures are proposed.
authors.affiliation: Division of Neurology, University Medicine Cluster, National University Health System, National University of Singapore, Singapore, Singapore. ramani_nv@nuhs.edu.sg
authors.forename: N
authors.initials: N
authors.lastname: Venketasubramanian
authors.forename: K H
authors.initials: KH
authors.lastname: Pwee
authors.forename: C P L
authors.initials: CP
authors.lastname: Chen
mesh_terms: D006801:Humans; D017130:Angioplasty; D000925:Anticoagulants / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology; D002544:Cerebral Infarction / Q000628:therapy; D016894:Endarterectomy, Carotid; D019317:Evidence-Based Medicine; D005334:Fever / Q000150:complications / Q000188:drug therapy; D016304:Hospitals, Private; D006779:Hospitals, Public; D006943:Hyperglycemia / Q000150:complications / Q000188:drug therapy; D007003:Hypoglycemia / Q000150:complications / Q000188:drug therapy; D002546:Ischemic Attack, Transient / Q000453:epidemiology / Q000601:surgery / Q000628:therapy; D019635:Neurosurgical Procedures; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D058996:Quality Improvement; D012308:Risk Management; D012846:Singapore; D015607:Stents; D020521:Stroke / Q000453:epidemiology / Q000601:surgery / Q000628:therapy; D054556:Venous Thromboembolism / Q000150:complications / Q000188:drug therapy
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors